What Is IL22RA1 and Why Does It Matter?

Interleukin-22 receptor subunit alpha-1 (IL22RA1, also designated IL-22RA1, IL22R, or CRF2-9) is a transmembrane glycoprotein belonging to the class II cytokine receptor superfamily. It serves as the ligand-binding subunit of the heterodimeric receptor complex that mediates signaling by IL-22, a cytokine produced predominantly by T helper 17 (Th17) cells, innate lymphoid cells (ILC3), and natural killer T cells.

Unlike many cytokine receptors, IL22RA1 expression is restricted almost exclusively to non-hematopoietic, epithelial, and stromal cell populations in barrier tissues—including the liver, kidney, lung, skin, pancreas, colon, and small intestine. This tissue-restricted expression pattern means IL-22 signaling through IL22RA1 is a critical mediator of epithelial barrier defense, mucosal immunity, and tissue repair, without directly activating circulating immune cells. This selectivity has made IL22RA1 an attractive target for therapeutic research in inflammatory bowel disease (IBD), psoriasis, and sepsis-associated organ damage.

Molecular Structure and Receptor Complex Assembly

IL22RA1 is a single-pass type I transmembrane protein encoded by the IL22RA1 gene located on human chromosome 1p36.11. The mature protein consists of an extracellular domain (ECD) containing conserved type III fibronectin-like modules characteristic of the class II cytokine receptor family, a single transmembrane helix, and a cytoplasmic tail that associates with Janus kinase 1 (JAK1).

Functional IL-22 signaling requires the assembly of a ternary complex: IL-22 first binds IL22RA1 with high affinity, and the resulting binary complex subsequently recruits the co-receptor IL-10 receptor subunit beta (IL10RB). This heterodimeric receptor platform brings JAK1 (constitutively associated with IL22RA1) and TYK2 (associated with IL10RB) into proximity, triggering transphosphorylation and downstream activation of STAT3 as the dominant transcription factor. STAT1 and mitogen-activated protein kinase (MAPK) pathways can also be engaged depending on cellular context.

A soluble form of IL22RA1 (sIL22RA1), generated by proteolytic shedding or alternative splicing, functions as a natural decoy receptor, binding free IL-22 and attenuating signaling—a regulatory mechanism of particular interest in inflammatory disease models.

Biological Functions and Disease Relevance

IL-22 signaling through IL22RA1 drives a broad range of protective epithelial responses. In the intestine, IL22RA1-mediated signaling promotes the production of antimicrobial peptides (e.g., RegIIIβ, RegIIIγ, defensins), mucin secretion, and tight junction reinforcement, collectively strengthening the mucosal barrier against luminal pathogens. In the liver, IL-22/IL22RA1 signaling is hepatoprotective, inducing acute-phase proteins and promoting hepatocyte survival following injury.

Dysregulation of IL22RA1 signaling is implicated in several inflammatory and autoimmune conditions. Excessive IL-22 activity has been documented in psoriasis, rheumatoid arthritis, and Crohn's disease, where sustained STAT3 activation downstream of IL22RA1 contributes to pathological tissue remodeling. Conversely, impaired IL-22/IL22RA1 signaling compromises epithelial regeneration and increases susceptibility to enteric infections.

In oncology, IL22RA1 has been identified as aberrantly expressed in certain gastrointestinal cancers, where it may promote tumor cell survival and proliferation via STAT3-driven gene programs. These findings position IL22RA1 as a dual-role mediator: protective in acute injury but potentially pathogenic in chronic inflammatory or neoplastic contexts.

Research Applications of Recombinant Human IL22RA1 Protein

Recombinant Human IL22RA1 Protein is a versatile reagent supporting multiple experimental workflows in cytokine biology and drug discovery:

• Binding and affinity studies: The purified extracellular domain of IL22RA1 is used in surface plasmon resonance (SPR), biolayer interferometry (BLI), and ELISA-based assays to characterize IL-22 binding kinetics, measure inhibitory antibody affinity, or map epitopes relevant to therapeutic development.
• Neutralization and blocking assays: Recombinant IL22RA1 protein serves as a competitive ligand to assess the blocking capacity of candidate anti-IL-22 or anti-IL22RA1 antibodies in vitro.
• Functional cell-based assays: When added exogenously, soluble IL22RA1 (ECD) can modulate cell responses to IL-22, enabling dose-response inhibition experiments in STAT3 reporter lines or primary epithelial cells.
• Immunoassay standards and controls: Recombinant IL22RA1 is used as a positive control antigen in Western blot, ELISA development, and immunohistochemistry validation.
• Structural and biophysical studies: High-purity recombinant protein provides material for X-ray crystallography or cryo-EM studies aimed at elucidating receptor-ligand complex architecture.

Researchers in immunology, gastroenterology, dermatology, and oncology will find Recombinant Human IL22RA1 Protein an essential reagent for mechanistic and translational investigations.

Handling, Storage, and Quality Considerations

To maintain the biological activity and structural integrity of Recombinant Human IL22RA1 Protein, adhere to the following best practices:

• Storage: Store lyophilized protein at –20 °C or –80 °C. Once reconstituted, prepare single-use aliquots and store at –80 °C to minimize freeze-thaw cycles, which can lead to aggregation and loss of binding activity.
• Reconstitution: Reconstitute in sterile phosphate-buffered saline (PBS) or the buffer specified in the product datasheet. Allow the vial to equilibrate to room temperature before opening. Carrier protein (e.g., 0.1% BSA) is recommended when working at very low concentrations to prevent adsorption to tube surfaces.
• Endotoxin levels: For functional cell-based assays, verify that endotoxin levels meet the requirements of your assay system. Low-endotoxin preparations are preferred for primary cell cultures.
• Quality verification: Confirm protein integrity by SDS-PAGE or SEC-HPLC, and confirm activity by a binding assay using a known IL-22 standard. Purity and identity data should be provided in the certificate of analysis (CoA).

Always consult the product-specific datasheet supplied by Aladdin Scientific for lot-specific storage conditions, concentration, and validated applications.